Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).
about
Surgery for local and locally advanced non-small cell lung cancerControversies regarding T status and N status for non-small cell lung cancerLung cancer ablation: technologies and techniques2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancerBronchoscopic evaluation of the mediastinum using endobronchial ultrasound: a description of the first 216 cases carried out at an Australian tertiary hospital.Lung cancer: current diagnosis and treatmentSurgical strategies in the therapy of non-small cell lung cancer.INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerRisk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapyUsing pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review.Mind-mapping for lung cancer: towards a personalized therapeutics approachDoes pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007.Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment.Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer.Direct nodal sampling by echoendoscopy in lung cancer: the clinician's expectations: Direct nodal sampling by echoendoscopy in lung cancer.Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status.Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center studyCurrent status of thermal ablation treatments for lung malignancies.Case Report: En Bloc Resection of Pancoast Tumor with Adjuvant Aortic Endograft and ChemoradiationHuman leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancerEvolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisalAdding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients.Surgery on unfavourable persistent N2/N3 non-small-cell lung cancer after trimodal therapy: do the results justify the risk?eComment. Should persistent N2/N3 non-small cell lung cancer be treated by surgery?Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection.Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor MicroenvironmentA retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery.Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancerWhat is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment ModalitiesPositron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).Controversies in the management of stage IIIA non-small-cell lung cancer.
P2860
Q24245182-E4A5A74F-5342-43F2-AF7D-73FCE64FEE1AQ26784282-4A622086-E460-4DEA-9556-C9CF7594728EQ26827382-827FDE06-AB3E-4AF6-ACDE-2404A8B06DF0Q27002509-5728580C-49E6-480A-A515-ADCA3911FEC7Q33517827-F2A08486-C3F8-4D7A-9F6F-37038012BB30Q33554085-6875107F-02EE-4D61-A2E5-4FCCE0499F3EQ34031208-A3ED7A80-60F7-47AE-8517-7B1C0B366429Q34044082-07791396-EEB3-4C72-AD90-D4CDAD5E5774Q34133236-CEB742BA-81B0-43D8-9C48-4709DAFA7B33Q34637882-1BF3E76A-10B9-41ED-8909-67D4D4B0B8BAQ34796086-9E71F8B4-E02A-4197-9473-E49342DEB649Q35039285-867E6B66-F841-4602-A1FA-CE84E4F78B73Q35134354-AB0D0629-3EFD-4185-AF08-78EBB6BF0636Q35147409-D1A0C167-ABE5-40B5-91AB-B77BF8BBE362Q35200402-FA32E8ED-1EE1-4F42-AAA0-DD705A14CE3BQ35634785-D0639AE9-D4FF-40C1-BD31-1B85E9FEAE6FQ35639032-DC3F55BE-9BFC-4D67-9BD2-948350D745C3Q35675562-0286FBC7-BFA2-4641-A419-62949EF0C9B0Q35681695-18A0E86C-8941-4A10-9203-722DD1BD1788Q35771994-CA330165-32E3-4A8B-A98D-8DAFEA3ADF1EQ35779914-78E0EADC-CFCD-48A6-B636-A0EF55C093FCQ35882898-8BBA969C-4ABE-4E6E-BC90-DCE27E619948Q35991092-22E8B284-31E7-4E34-B8E9-83F86D0F898AQ36051715-F66336F7-0EC7-4546-A320-AA59C37E58D7Q36247875-2BD5F412-6BB4-4421-B589-AB4BA96E06B7Q36296453-FC036F93-C383-4941-9AA0-5E9EC9711F7CQ36308285-548E6CE3-9B66-4D0C-991F-64CD0B44FE30Q36384058-8F82A956-00B4-4EA7-AFE8-2854818D1DA7Q36408837-19B820C3-DBB2-439E-96AB-49FA875FA55FQ36408909-DD7C6B6B-7A2E-485D-962B-5C54205F57F7Q36480009-7E0914F2-698E-4CF8-9299-E5F1417A93BEQ36603426-D11A24C2-0131-4191-AD4B-64C870A1097AQ36752521-A0915451-965E-43DF-B813-DB1E75CF009CQ36850130-280DFFBF-EB2F-4D44-B61C-1DFE46DB32A7Q36852163-7E455AEE-C40F-496E-BF4E-A91E694A5DDDQ37085999-2591B737-51C5-40DA-9113-6C546F34448AQ37099236-2E81A6D6-A62A-4B78-9BE1-B09A39EEF795Q37245399-1DAC84F5-B2C8-4D4B-AC5F-AE047BADAF85Q37301288-72537779-BE3F-4B09-A74C-3A968C07A387Q37338248-13A81BEE-BE3A-498A-AE8B-81A21189EE9B
P2860
Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@ast
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@en
Treatment of non-small cell lu ...... d clinical practice guidelines
@nl
type
label
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@ast
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@en
Treatment of non-small cell lu ...... d clinical practice guidelines
@nl
prefLabel
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@ast
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@en
Treatment of non-small cell lu ...... d clinical practice guidelines
@nl
P2093
P356
P1433
P1476
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@en
P2093
Craig W Stevens
Henry Wagner
Lary A Robinson
P304
P356
10.1378/CHEST.07-1379
P407
P433
P577
2007-09-01T00:00:00Z